Cargando…

Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue

Children with Down syndrome (DS) suffer from recurrent respiratory infections, which represent the leading cause of mortality during childhood. This susceptibility to infections is usually considered multifactorial and related to both impaired immune function and non-immunological factors. Infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Dieudonné, Yannick, Uring-Lambert, Beatrice, Jeljeli, Mohamed Maxime, Gies, Vincent, Alembik, Yves, Korganow, Anne-Sophie, Guffroy, Aurélien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225335/
https://www.ncbi.nlm.nih.gov/pubmed/32457756
http://dx.doi.org/10.3389/fimmu.2020.00840
_version_ 1783534067196624896
author Dieudonné, Yannick
Uring-Lambert, Beatrice
Jeljeli, Mohamed Maxime
Gies, Vincent
Alembik, Yves
Korganow, Anne-Sophie
Guffroy, Aurélien
author_facet Dieudonné, Yannick
Uring-Lambert, Beatrice
Jeljeli, Mohamed Maxime
Gies, Vincent
Alembik, Yves
Korganow, Anne-Sophie
Guffroy, Aurélien
author_sort Dieudonné, Yannick
collection PubMed
description Children with Down syndrome (DS) suffer from recurrent respiratory infections, which represent the leading cause of mortality during childhood. This susceptibility to infections is usually considered multifactorial and related to both impaired immune function and non-immunological factors. Infections are also one of the top causes of death in DS at adulthood. DS is considered an immunodeficiency with syndromic features by some researchers because of this high rate of infection and the immunological characteristics observed in children with DS. Little is known about the immune status of adult patients. Herein, we report the clinical and immune phenotype of 44 adults with DS, correlated with their infectious history. We observed that these adults had an aberrant lymphocyte phenotype with decreased naïve/memory T cell ratios and reduced numbers of switched memory B cells. The lower incidence of infectious events at adulthood distinguish DS from other inborn errors of immunity. Primary immunodeficiency-related features in DS could explain the increased risk of developing autoimmunity, malignancies, and infections. During adulthood, this immune dysfunction may be compensated for in mid-life, and infection-related mortality observed in older patients might be favored by multiple factors such as neurological impairment or nosocomial antigen exposure. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT01663675 (August 13, 2012).
format Online
Article
Text
id pubmed-7225335
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72253352020-05-25 Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue Dieudonné, Yannick Uring-Lambert, Beatrice Jeljeli, Mohamed Maxime Gies, Vincent Alembik, Yves Korganow, Anne-Sophie Guffroy, Aurélien Front Immunol Immunology Children with Down syndrome (DS) suffer from recurrent respiratory infections, which represent the leading cause of mortality during childhood. This susceptibility to infections is usually considered multifactorial and related to both impaired immune function and non-immunological factors. Infections are also one of the top causes of death in DS at adulthood. DS is considered an immunodeficiency with syndromic features by some researchers because of this high rate of infection and the immunological characteristics observed in children with DS. Little is known about the immune status of adult patients. Herein, we report the clinical and immune phenotype of 44 adults with DS, correlated with their infectious history. We observed that these adults had an aberrant lymphocyte phenotype with decreased naïve/memory T cell ratios and reduced numbers of switched memory B cells. The lower incidence of infectious events at adulthood distinguish DS from other inborn errors of immunity. Primary immunodeficiency-related features in DS could explain the increased risk of developing autoimmunity, malignancies, and infections. During adulthood, this immune dysfunction may be compensated for in mid-life, and infection-related mortality observed in older patients might be favored by multiple factors such as neurological impairment or nosocomial antigen exposure. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT01663675 (August 13, 2012). Frontiers Media S.A. 2020-05-08 /pmc/articles/PMC7225335/ /pubmed/32457756 http://dx.doi.org/10.3389/fimmu.2020.00840 Text en Copyright © 2020 Dieudonné, Uring-Lambert, Jeljeli, Gies, Alembik, Korganow and Guffroy. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Dieudonné, Yannick
Uring-Lambert, Beatrice
Jeljeli, Mohamed Maxime
Gies, Vincent
Alembik, Yves
Korganow, Anne-Sophie
Guffroy, Aurélien
Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue
title Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue
title_full Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue
title_fullStr Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue
title_full_unstemmed Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue
title_short Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue
title_sort immune defect in adults with down syndrome: insights into a complex issue
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225335/
https://www.ncbi.nlm.nih.gov/pubmed/32457756
http://dx.doi.org/10.3389/fimmu.2020.00840
work_keys_str_mv AT dieudonneyannick immunedefectinadultswithdownsyndromeinsightsintoacomplexissue
AT uringlambertbeatrice immunedefectinadultswithdownsyndromeinsightsintoacomplexissue
AT jeljelimohamedmaxime immunedefectinadultswithdownsyndromeinsightsintoacomplexissue
AT giesvincent immunedefectinadultswithdownsyndromeinsightsintoacomplexissue
AT alembikyves immunedefectinadultswithdownsyndromeinsightsintoacomplexissue
AT korganowannesophie immunedefectinadultswithdownsyndromeinsightsintoacomplexissue
AT guffroyaurelien immunedefectinadultswithdownsyndromeinsightsintoacomplexissue